Letters to the Editor

Update and European consensus on a patient-centered core outcome set for multiple myeloma in clinical practice and research

Department of Research and development, Netherlands Comprehensive Cancer Organisation, Utrecht
Department of Research and development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands; CoRPS - Center of Research on Psychology in Somatic diseases, Department of Medical and Clinical Psychology, Tilburg University, Tilburg
Department of Strategy, Amphia, Breda, the Netherlands; Department of Haematology, Erasmus Medical Center Cancer Institute, Rotterdam
Department of Hematology, Oncology and Cancer Immunology, Campus Virchow, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Department of Haematology, Erasmus Medical Center Cancer Institute, Rotterdam
Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy
Hematology-Oncology Clinic; University of Tartu, Tartu, Estonia
Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
Hematology Department, Cancer University Institute Oncopole, Toulouse
Department of Haematology, Erasmus Medical Center Cancer Institute, Rotterdam
European Myeloma Network Romania
Myeloma Patients Europe
Myeloma Patients Europe
Takeda Development Center Americas, Inc., Lexington, MA
Abbvie
Institute of Outcomes Research, Center for Medical Data Science, Medical University of Vienna, Austria and Ludwig Boltzmann Institute for Arthritis and Rehabilitation, Vienna, Austria
Wilhelminen Cancer Research Institute, First Department of Medicine, Center for Oncology, Hematology, and Palliative Care, Clinic Ottakring, Vienna, Austria
Department of Haematology, Erasmus Medical Center Cancer Institute, Rotterdam
Haematologica Early view Feb 1, 2024 https://doi.org/10.3324/haematol.2023.284282